Genosafe SAS

Genosafe SAS is an SME in Evry-Courcouronnes, France that has taken part in 6 EU-funded projects since 2012, receiving €2.9M in EU funding.

EU funding received€2.9M
EU projects6
As coordinator0
Running now0
First EU project2012
Latest project2020
CountryFrance
EU registration (PIC)968944447
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Genosafe SAS's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€1.9M · 3 projects
  • Horizon 2020€961k · 3 projects

Projects

6 EU-funded projects, newest first. Each links to the official record.

  • ARDATPartner

    Accelerating Research & Development for Advanced Therapies

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €300ktheir share
  • UshTherPartner

    Clinical trial of gene therapy with dual AAV vectors for retinitis pigmentosa in patients with Usher syndrome type IB

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €528ktheir share
  • CureCNPartner

    Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €133ktheir share
  • MEUSIXPartner

    Clinical trial of gene therapy for MPS VI - a severe lysosomal storage disorder

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

    €777ktheir share
  • NET4CGDPartner

    Gene Therapy for X-linked Chronic Granulomatous Disease (CGD)

    FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

    €852ktheir share
  • TARGETAMDPartner

    Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (AMD)

    FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

    €292ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • development studies
  • drug safety
  • enzymes
  • gene therapy
  • genomes
  • history
  • immunology
  • implants
  • mutation
  • neurobiology
  • ophthalmology
  • stem cells
  • virology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime